Abstract
A series of triazoles have been prepared and evaluated as inhibitors of InhA as well as inhibitors of Mycobacterium tuberculosis H(37)R(v). Several of these new compounds possess a good activity against InhA, particularly compounds 17 and 18 for which molecular docking has been performed. Concerning their activities against M. tuberculosis H(37)R(V) strain, two of them, 3 and 12, were found to be good inhibitors with MIC values of 0.50 and 0.25 μg/mL, respectively. Particularly, compound 12 presenting the best MIC value of all compounds tested (0.6 μM) is totally inactive against InhA.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antitubercular Agents / chemical synthesis
-
Antitubercular Agents / chemistry
-
Antitubercular Agents / pharmacology
-
Bacterial Proteins / antagonists & inhibitors*
-
Bacterial Proteins / chemistry
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Models, Molecular
-
Mycobacterium tuberculosis / drug effects*
-
Mycobacterium tuberculosis / enzymology*
-
Oxidoreductases / antagonists & inhibitors*
-
Oxidoreductases / chemistry
-
Protein Conformation
-
Triazoles / chemical synthesis*
-
Triazoles / chemistry
-
Triazoles / pharmacology*
Substances
-
Antitubercular Agents
-
Bacterial Proteins
-
Enzyme Inhibitors
-
Triazoles
-
Oxidoreductases
-
InhA protein, Mycobacterium